Clinical Genitourinary Cancer

2.1k papers and 25.1k indexed citations i.

About

The 2.1k papers published in Clinical Genitourinary Cancer in the last decades have received a total of 25.1k indexed citations. Papers published in Clinical Genitourinary Cancer usually cover Pulmonary and Respiratory Medicine (1.4k papers), Surgery (841 papers) and Oncology (578 papers) specifically the topics of Prostate Cancer Treatment and Research (642 papers), Renal cell carcinoma treatment (628 papers) and Bladder and Urothelial Cancer Treatments (618 papers). The most active scholars publishing in Clinical Genitourinary Cancer are Brian I. Rini, Guru Sonpavde, Nicholas J. Vogelzang, Shahrokh F. Shariat and Toni K. Choueiri.

In The Last Decade

Fields of papers published in Clinical Genitourinary Cancer

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Clinical Genitourinary Cancer. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Clinical Genitourinary Cancer

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Clinical Genitourinary Cancer. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Clinical Genitourinary Cancer with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025